NEW MJ NEWS

AbbVie to Host Second-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its second-quarter 2022 financial results on Friday, July 29, 2022, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2022-earnings-conference-call-301582507.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tetra Bio-Pharma Inc. (TBPMF) Announces a Delay in Filing 2022 Annual Financial Statements

Tetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements…

$MSRT Provides Business Update and Company Outlook

MassRoots Provides Business Update and Company Outlook MassRoots, Inc. (MSRT), one of…

MustGrow Biologics Corp. (MGROF) Provides Additional Information and Clarification on Commercial License Agreement with Bayer

MustGrow Provides Additional Information and Clarification on Commercial License Agreement with Bayer…